(CE) Celanese - Ratings and Ratios
Acetic Acid, Vinyl Acetate, Nylon Compounds, Polyoxymethylene, Polyethylene
Dividends
| Dividend Yield | 0.30% |
| Yield on Cost 5y | 0.10% |
| Yield CAGR 5y | 3.08% |
| Payout Consistency | 99.0% |
| Payout Ratio | 2.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 61.8% |
| Value at Risk 5%th | 88.5% |
| Relative Tail Risk | -12.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.69 |
| Alpha | -68.41 |
| CAGR/Max DD | -0.33 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.581 |
| Beta | 1.706 |
| Beta Downside | 2.159 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.96% |
| Mean DD | 30.91% |
| Median DD | 18.12% |
Description: CE Celanese November 06, 2025
Celanese Corporation (NYSE: CE) is a diversified chemical and specialty-materials producer that operates two primary segments: Engineered Materials, which supplies a broad portfolio of high-performance polymers (e.g., nylon, polyoxymethylene, liquid-crystal polymers, thermoplastic elastomers) to end-markets such as automotive, medical, energy-storage and consumer electronics; and Acetyl Chain, which manufactures acetyl-based intermediates (acetic acid, vinyl acetate monomer, ethylene-vinyl acetate resins, etc.) used in paints, adhesives, flexible packaging and pharmaceuticals.
Key operating metrics from the most recent fiscal year (2024) show net sales of $9.2 billion, with the Engineered Materials segment contributing roughly 55 % of revenue and delivering an adjusted EBITDA margin of 14.8 % versus 13.2 % in the prior year, reflecting higher demand for lightweight automotive plastics and battery-case polymers. The Acetyl Chain segment posted a 4 % YoY revenue increase, driven by a rebound in vinyl-acetate demand as global packaging volumes recover post-COVID-19. Utilization rates across Celanese’s U.S. and European facilities averaged 78 % in 2024, above the industry-wide average of 71 %.
Sector-wide, the specialty-chemicals market is being shaped by three macro drivers: (1) the electrification of transportation, which raises demand for high-temperature, flame-retardant polymers; (2) the rapid growth of renewable-energy storage, boosting consumption of polyolefin-based battery casings; and (3) tightening environmental regulations that increase the premium on low-VOC, bio-based resin solutions-areas where Celanese’s R&D pipeline is focused.
Investors seeking a deeper, data-driven view of Celanese’s valuation assumptions and scenario analyses may find the free research tools on ValueRay useful for extending this high-level overview.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-3.09b TTM) > 0 and > 6% of Revenue (6% = 582.6m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 1.36pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 24.34% (prev 14.76%; Δ 9.57pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 1.39b > Net Income -3.09b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.63 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (109.6m) change vs 12m ago 0.06% (target <= -2.0% for YES) |
| Gross Margin 21.33% (prev 23.19%; Δ -1.86pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.41% (prev 40.47%; Δ -0.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -2.86 (EBITDA TTM -1.28b / Interest Expense TTM 719.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.11
| (A) 0.11 = (Total Current Assets 6.09b - Total Current Liabilities 3.73b) / Total Assets 22.17b |
| (B) 0.44 = Retained Earnings (Balance) 9.86b / Total Assets 22.17b |
| (C) -0.09 = EBIT TTM -2.06b / Avg Total Assets 24.03b |
| (D) 0.51 = Book Value of Equity 9.01b / Total Liabilities 17.79b |
| Total Rating: 2.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 31.94
| 1. Piotroski 3.0pt |
| 2. FCF Yield 6.46% |
| 3. FCF Margin 10.55% |
| 4. Debt/Equity 3.32 |
| 5. Debt/Ebitda -9.10 |
| 6. ROIC - WACC (= -15.56)% |
| 7. RoE -63.15% |
| 8. Rev. Trend 9.64% |
| 9. EPS Trend -78.31% |
What is the price of CE shares?
Over the past week, the price has changed by -4.35%, over one month by +6.70%, over three months by -14.13% and over the past year by -43.67%.
Is CE a buy, sell or hold?
- Strong Buy: 5
- Buy: 0
- Hold: 12
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the CE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 52.5 | 31.8% |
| Analysts Target Price | 52.5 | 31.8% |
| ValueRay Target Price | 32.7 | -17.9% |
CE Fundamental Data Overview November 25, 2025
P/E Forward = 6.2735
P/S = 0.4278
P/B = 1.0505
P/EG = 4.4198
Beta = 1.13
Revenue TTM = 9.71b USD
EBIT TTM = -2.06b USD
EBITDA TTM = -1.28b USD
Long Term Debt = 11.65b USD (from longTermDebt, last quarter)
Short Term Debt = 1.20b USD (from shortTermDebt, last quarter)
Debt = 13.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.69b USD (from netDebt column, last quarter)
Enterprise Value = 15.85b USD (4.15b + Debt 13.13b - CCE 1.44b)
Interest Coverage Ratio = -2.86 (Ebit TTM -2.06b / Interest Expense TTM 719.0m)
FCF Yield = 6.46% (FCF TTM 1.02b / Enterprise Value 15.85b)
FCF Margin = 10.55% (FCF TTM 1.02b / Revenue TTM 9.71b)
Net Margin = -31.85% (Net Income TTM -3.09b / Revenue TTM 9.71b)
Gross Margin = 21.33% ((Revenue TTM 9.71b - Cost of Revenue TTM 7.64b) / Revenue TTM)
Gross Margin QoQ = 21.54% (prev 21.13%)
Tobins Q-Ratio = 0.71 (Enterprise Value 15.85b / Total Assets 22.17b)
Interest Expense / Debt = 1.35% (Interest Expense 177.0m / Debt 13.13b)
Taxrate = 0.51% (-7.00m / -1.36b)
NOPAT = -2.05b (EBIT -2.06b * (1 - 0.51%)) [loss with tax shield]
Current Ratio = 1.63 (Total Current Assets 6.09b / Total Current Liabilities 3.73b)
Debt / Equity = 3.32 (Debt 13.13b / totalStockholderEquity, last quarter 3.95b)
Debt / EBITDA = -9.10 (negative EBITDA) (Net Debt 11.69b / EBITDA -1.28b)
Debt / FCF = 11.42 (Net Debt 11.69b / FCF TTM 1.02b)
Total Stockholder Equity = 4.90b (last 4 quarters mean from totalStockholderEquity)
RoA = -13.95% (Net Income -3.09b / Total Assets 22.17b)
RoE = -63.15% (Net Income TTM -3.09b / Total Stockholder Equity 4.90b)
RoCE = -12.44% (EBIT -2.06b / Capital Employed (Equity 4.90b + L.T.Debt 11.65b))
RoIC = -11.58% (negative operating profit) (NOPAT -2.05b / Invested Capital 17.69b)
WACC = 3.97% (E(4.15b)/V(17.29b) * Re(12.30%) + D(13.13b)/V(17.29b) * Rd(1.35%) * (1-Tc(0.01)))
Discount Rate = 12.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.05%
[DCF Debug] Terminal Value 60.07% ; FCFE base≈952.0m ; Y1≈788.7m ; Y5≈574.3m
Fair Price DCF = 54.13 (DCF Value 5.93b / Shares Outstanding 109.5m; 5y FCF grow -20.68% → 3.0% )
EPS Correlation: -78.31 | EPS CAGR: -29.27% | SUE: 0.47 | # QB: 0
Revenue Correlation: 9.64 | Revenue CAGR: 1.65% | SUE: -1.42 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.95 | Chg30d=+0.045 | Revisions Net=+0 | Analysts=9
EPS next Year (2026-12-31): EPS=5.64 | Chg30d=-0.125 | Revisions Net=-6 | Growth EPS=+32.6% | Growth Revenue=+0.5%
Additional Sources for CE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle